<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00663520</url>
  </required_header>
  <id_info>
    <org_study_id>Study #3631</org_study_id>
    <nct_id>NCT00663520</nct_id>
  </id_info>
  <brief_title>Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women</brief_title>
  <acronym>MVD</acronym>
  <official_title>Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if women with chest pain and &quot;clean&quot; heart blood&#xD;
      vessels have impaired blood flow to the heart due to problems with the small blood vessels&#xD;
      that provide blood and oxygen to the heart. Impairment in the small blood vessels will be&#xD;
      tested using ultrasound pictures of the heart, called myocardial contrast echocardiography.&#xD;
      Since these small blood vessels are not seen in a coronary angiogram, which is an x-ray of&#xD;
      the heart vessels using a dye containing iodine injected in the heart vessels, the problem&#xD;
      may remain undiagnosed in women until the heart muscle becomes severely damaged.&#xD;
&#xD;
      A second purpose is to identify if there is a common trait in the population of women with&#xD;
      this tiny blood vessel dysfunction, which will be investigated by checking blood levels of&#xD;
      certain chemical and hormones related to heart disease. Finally, we would like to investigate&#xD;
      the relationship between depression and stress, and heart disease. We will do this by&#xD;
      measuring cortisol (a hormone that serves as a measure of stress) and administering&#xD;
      questionnaires that help to identify depression and stress.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Elucidating the Role of Microvascular Dysfunction in Heart Disease in Women</measure>
    <time_frame>2008-2014</time_frame>
    <description>Data collection</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Microvascular Dysfunction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Women with chest pain and &quot;Clean&quot; heart vessels</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Healthy volunteers</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Fifty non-smoking women, between 45 and 75 years of age, with chest pain will be referred&#xD;
        to this study by clinicians at OHSU. The control group will be fifty non-smoking women with&#xD;
        no cardiac symptoms, matched with the study group by age and risk factors. Flyers and other&#xD;
        advertisements may be used to recruit both the study group and the control group. Criteria&#xD;
        for exclusion from the study are pregnancy, allergy to any component in the drugs used in&#xD;
        the study, severe asthma, known disease of the heart vessels or heart valves, active&#xD;
        infection, cancer, uncontrolled hypertension, kidney disease and current smoking status.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women 45 to 75 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Allergy to any component of the drugs: DefinityÂ®. Dipyridamole Aminophyllin or Iodine.&#xD;
&#xD;
          -  Known coronary heart disease, significant valvular disease (valvular stenosis or&#xD;
             insufficiency greater than moderate) left ventricular systolic dysfunction, congenital&#xD;
             heart disease or cardiac shunt, pulmonary hypertension, moderate or severe asthma.&#xD;
&#xD;
          -  Inability to reach the patient by mail, fax, e-mail or phone&#xD;
&#xD;
          -  Active infection&#xD;
&#xD;
          -  Malignancy&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Severe asthma&#xD;
&#xD;
          -  Kidney disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diana Rinkevich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>April 18, 2008</study_first_submitted>
  <study_first_submitted_qc>April 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2008</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Elizabeth Cannar</investigator_full_name>
    <investigator_title>Diana Rinkevich, MD</investigator_title>
  </responsible_party>
  <keyword>Cardiac disease</keyword>
  <keyword>vascular dysfunction</keyword>
  <keyword>women</keyword>
  <keyword>chest pain</keyword>
  <keyword>echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No Plan to share data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

